Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroInDx is a biotechnology company that develops and commercializes advanced instrumentation for single-cell isolation and complex tissue microdissection. Its core technology, based on a patented vacuum pulse-based acquisition system, allows researchers to precisely collect individual cells or specific tissue regions from various biological samples, including cell cultures and FFPE specimens. These tools, such as the UnipicK and A-picK systems, are designed to be compatible with standard inverted microscopes and are used in fields like neuroscience, oncology, and genomics. By enabling high-resolution sample collection with minimal impact on cell viability and molecular integrity, NeuroInDx supports downstream applications like single-cell RNA sequencing and proteomics. The company is headquartered in Torrance, California, and serves a global customer base in academia and the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroInDx.